Drug intelligence / Profile preview

tetracaine

Development stage
Approved
Lead developer
Alcon
Modality
Small Molecules
Administration
Ophthalmic, Topical, Intrathecal, Intranasal, Otic, Transdermal
01

Overview

Tetracaine is a long-lasting ester-type local anesthetic used primarily for surface anesthesia of the eyes, nose, throat, and mucous membranes. It is also applied to the skin before procedures such as intravenous cannulation to reduce pain. Tetracaine works by blocking voltage-gated sodium channels on nerve cell membranes, thereby inhibiting nerve impulse conduction and producing localized numbness. Its onset of action in the eye occurs within about 30 seconds and lasts less than 15 minutes when used topically. In clinical practice, it is considered much more potent than procaine and has a duration of action lasting up to several hours depending on the route of administration[1][2][6]. It may be used alone or in combination with other agents (e.g., lidocaine or adrenaline). In biomedical research, tetracaine can also act as an allosteric blocker of ryanodine receptors involved in calcium release from intracellular stores[2][8].

Brand names
PontocaineAmetopDicaineAltacaineTetcaineTetraViscTetraVisc ForteCetacaineKovanazePliaglisSynera
Other names
丁卡因2-(dimethylamino)ethyl 4-(butylamino)benzoate
02

Targets

NaV (Voltage-gated sodium channels)

Beyond the preview

Go deeper on tetracaine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on tetracaine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call